Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 2-((4s)-6-(4-chlorophenyl)-8-methoxy-1-methyl-4h-(1,2,4)triazolo(4,3-a)(1,4)benzodiazepin-4-yl)-n-ethylacetamide Monobenzenesulfonate Salt
2. Gsk 525762a
3. Gsk-525762a
4. Gsk525762
5. Gsk525762a
6. I-bet Compound
7. I-bet762
8. Ibet Compound
9. Molibresib
10. Molibresib Besylate
1. 1260907-17-2
2. Molibresib
3. I-bet-762
4. Gsk 525762a
5. Gsk525762a
6. Gsk525762
7. I-bet 762
8. Gsk-525762
9. I-bet762
10. Gsk-525762a
11. Bet Inhibitor Gsk525762
12. (s)-2-(6-(4-chlorophenyl)-8-methoxy-1-methyl-4h-benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepin-4-yl)-n-ethylacetamide
13. 5qio6srz2r
14. Chembl1232461
15. Molibresib (usan)
16. Cs-0717
17. Molibresib [usan]
18. Gsk-525762a (i-bet 762)
19. 4h-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine-4-acetamide, 6-(4-chlorophenyl)-n-ethyl-8-methoxy-1-methyl-, (4s)-
20. Eam
21. Unii-5qio6srz2r
22. 2yek
23. Ibet
24. (4s)-6-(4-chlorophenyl)-n-ethyl-8-methoxy-1-methyl-4h-(1,2,4)triazolo(4,3-a)(1,4)benzodiazepine-4-acetamide
25. (4s)-6-(4-chlorophenyl)-n-ethyl-8-methoxy-1-methyl-4h-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine-4-acetamide
26. (s)-2-(6-(4-chlorophenyl)-8-methoxy-1-methyl-4h-benzo-[f][1,2,4]triazolo[4,3-a][1,4]diazepin-4-yl)-n-ethylacetamide
27. 4h-(1,2,4)triazolo(4,3-a)(1,4)benzodiazepine-4-acetamide, 6-(4-chlorophenyl)-n-ethyl-8-methoxy-1-methyl-, (4s)-
28. 3p5o
29. Molibresib [inn]
30. Molibresib [who-dd]
31. Molibresib (i-bet-762)
32. Gtpl7033
33. Schembl1872390
34. Chebi:95082
35. Dtxsid60677590
36. Ex-a462
37. Bcp07337
38. Bdbm50365463
39. Mfcd22417091
40. Nsc774829
41. S7189
42. Zinc58655571
43. Akos025404837
44. Ccg-208698
45. Nsc-774829
46. Ncgc00263621-02
47. Ncgc00263621-04
48. Ncgc00263621-06
49. Ac-32712
50. As-16364
51. Bp-23442
52. Hy-13032
53. Gsk-525762a(i-bet-762)
54. I-bet762, >=98% (hplc)
55. B1498
56. Sw220225-1
57. D11326
58. J-005327
59. Q27078016
60. 2-((4s)-6-(4-chlorophenyl)-8-methoxy-1-methyl-4h-benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepin-4-yl)-n-ethylacetamide
61. 2-((4s)-6-(4-chlorophenyl)-8-methoxy-1-methyl-4hbenzo(f)(1,2,4)triazolo(4,3-a)(1,4)diazepin-4-yl)-n-ethylacetamide
62. 2-[(4s)-6-(4-chlorophenyl)-1-methyl-8-(methyloxy)-4h-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-4-yl]-n-ethylacetamide
| Molecular Weight | 423.9 g/mol |
|---|---|
| Molecular Formula | C22H22ClN5O2 |
| XLogP3 | 2.9 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 5 |
| Exact Mass | 423.1462027 g/mol |
| Monoisotopic Mass | 423.1462027 g/mol |
| Topological Polar Surface Area | 81.4 Ų |
| Heavy Atom Count | 30 |
| Formal Charge | 0 |
| Complexity | 639 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Treatment of breast cancer
ABOUT THIS PAGE
A Molibresib manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Molibresib, including repackagers and relabelers. The FDA regulates Molibresib manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Molibresib API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Molibresib supplier is an individual or a company that provides Molibresib active pharmaceutical ingredient (API) or Molibresib finished formulations upon request. The Molibresib suppliers may include Molibresib API manufacturers, exporters, distributors and traders.
Molibresib Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Molibresib GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Molibresib GMP manufacturer or Molibresib GMP API supplier for your needs.
A Molibresib CoA (Certificate of Analysis) is a formal document that attests to Molibresib's compliance with Molibresib specifications and serves as a tool for batch-level quality control.
Molibresib CoA mostly includes findings from lab analyses of a specific batch. For each Molibresib CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Molibresib may be tested according to a variety of international standards, such as European Pharmacopoeia (Molibresib EP), Molibresib JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Molibresib USP).
LOOKING FOR A SUPPLIER?
